Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein,

Sibel Gulcicek1, Carmine Zoccali2, Deniz Çebi Olgun3

  • 1Division of Nephrology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

Cardiorenal Medicine
|November 10, 2017
PubMed

Insights

Coronary artery calcification (CAC) progresses long-term in renal transplant recipients. This progression is not explained by traditional risk factors or kidney/bone disease biomarkers, suggesting other unmeasured factors are involved.

Area of Science:

  • Cardiology
  • Nephrology
  • Radiology

Background:

  • Renal transplant recipients face higher mortality rates than the general population.
  • Coronary artery calcification (CAC) progression is linked to mortality in the general population.
  • Studying CAC progression in transplant patients may illuminate long-term coronary heart disease risks.

Purpose of the Study:

  • To investigate the long-term progression of coronary artery calcification (CAC) in renal transplant recipients.
  • To identify predictors of CAC evolution in this patient group.
  • To determine if traditional risk factors, renal dysfunction biomarkers, or bone mineral disorder biomarkers influence CAC progression.

Main Methods:

  • A cohort of 113 renal transplant patients was followed.
  • Three multi-detector computed tomography scans were performed over approximately 83.6 months.
  • Data were analyzed using logistic regression and mixed linear modeling.

Main Results:

  • Coronary artery calcification (CAC) progression was observed in 34.5% of patients.
  • Baseline CAC and time-to-transplantation were the only predictors of CAC evolution.
  • Neither classical/nontraditional risk factors nor biomarkers of renal function, kidney damage, or bone mineral disorder were associated with CAC progression.

Conclusions:

  • Coronary artery calcification (CAC) continues to progress long-term in renal transplant patients.
  • This progression is not accounted for by known risk factors or biomarkers of renal dysfunction/damage.
  • Unmeasured factors likely play a significant role in promoting CAC evolution in transplant recipients.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
545
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
798
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
494
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
622
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K